12 Active Studies

Deep Vein Thrombosis Clinical Trials

Find actively recruiting research studies for deep vein thrombosis. Connect with study sites near you and explore new treatment options.

12
Active Trials
62+
Locations
4,100
Participants Needed

Recruiting Studies

RecruitingNCT07015905

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim...

4 locations(Englewood, Sarasota, Tamarac)
2,000 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNCT05171075

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with ...

10 locations(Aurora, Washington D.C., Miami)
1,020 participants
Anthos Therapeutics, Inc.
View Study Details
RecruitingNCT04924322

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous th...

10 locations(Birmingham, Little Rock, Aurora)
258 participants
Yale University
View Study Details
RecruitingNCT06299111

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)

This study is researching 2 different experimental drugs called REGN9933 and REGN7508 (called "study drugs"). The study is focused on adults undergoing a placement of a catheter in the vein, also call...

10 locations(Miami, Boston, Detroit)
195 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNCT06379789

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study is researching an ex...

10 locations(Los Angeles, Los Angeles, Los Angeles)
130 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNCT05641753

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

This is a prospective, interventional, cohort study, meaning that researchers will follow and observe a group of enrolled study participants over a period of time (one to two months) to gather informa...

4 locations(New York, New York, New York)
125 participants
NYU Langone Health
View Study Details
RecruitingNCT05844501

Ondansetron for the Management of Atrial Fibrillation

"Afib" is a common irregular heartbeat. Afib can cause stroke, blood clots, dementia and death. Medicines used to treat Afib often do not work well and can cause serious side effects. Clinicians need ...

3 locations(Indianapolis, Indianapolis, Indianapolis)
80 participants
Indiana University
View Study Details
RecruitingNCT04862468

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

This is a study of a medical procedure that utilizes a commercially available catheter (the Bullfrog® Micro-Infusion Device) to locally deliver a commercially available anti-inflammatory drug (dexamet...

10 locations(Orange, Darien, Atlantis)
80 participants
Mercator MedSystems, Inc.
View Study Details
RecruitingNCT04683003

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to t...

10 locations(Atlanta, Buffalo, Durham)
77 participants
Takeda
View Study Details
RecruitingNCT04858776

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

This is a study of a medical procedure that utilizes a commercially available catheter (the Bullfrog® Micro-Infusion Device) to locally deliver a commercially available anti-inflammatory drug (dexamet...

10 locations(Darien, Tampa, Chicago)
60 participants
Mercator MedSystems, Inc.
View Study Details
RecruitingNCT05399537

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Prismocitrate 18 is a continuous renal replacement therapy (CRRT) solution to be used as a renal replacement solution and as an anticoagulant to prevent blood clotting in the extracorporeal circuit. T...

10 locations(Birmingham, Los Angeles, Los Angeles)
40 participants
Vantive Health LLC
View Study Details
RecruitingNCT06866964

A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

The purpose of this study is to the 6-month Venous Thromboembolism (VTE)-free rate in participants with advanced germ cell cancer at high risk of VTE who are receiving standard of care cisplatin-based...

2 locations(Charlotte, Winston)
35 participants
Wake Forest University Health Sciences
View Study Details

Frequently Asked Questions

What clinical trials are available for Deep Vein Thrombosis?

There are currently 12 actively recruiting clinical trials for deep vein thrombosis. These studies are testing new treatments, therapies, and interventions at research sites across 62 cities.

How do I join a Deep Vein Thrombosis clinical trial?

To join a deep vein thrombosis clinical trial: 1) Browse the available studies above, 2) Click on a study that interests you, 3) Complete the eligibility form, and 4) A study coordinator will contact you.

Are clinical trials free for patients?

Yes, clinical trial participation is free. In most studies, the treatment, medical tests, and doctor visits related to the trial are provided at no cost. Some studies may also compensate for time and travel.

Can I leave a clinical trial if I change my mind?

Yes, participation in any clinical trial is completely voluntary. You can withdraw at any time, for any reason, without affecting your regular medical care.